Financials
Financial year 2024
Worth noting
- Little cash and receivables against the short-term debts.
Revenue
€ 6.9 million
▲ 23% vs 2023
Profit
Caution€ -16.1 million
▼ 137% vs 2023
Debts
Low€ 29.6 million
▼ 58% vs 2023
A.forall Group from Anderlecht, company number BE0684777042, closed financial year 2024 with a result of € -16.1 million after tax. For that financial year A.forall Group recorded revenue of € 6.9 million and equity of € 127 million. Compared with financial year 2023, the result moved from € 43.5 million to € -16.1 million. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on November 24, 2025.
What happened at A.forall Group?
What happened at A.forall Group in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Themtis BV stepped down as director. NBB
- Karsten Langer stepped down as director. NBB
- Damien Gaudin stepped down as director. NBB
- George Frederick Wilkinson stepped down as director. NBB
- Pharma Handshake BV stepped down as director. NBB
- VS Pharma Consulting LLC stepped down as director. NBB
- New annual accounts for financial year 2024: loss of € 16.1 million (▼ 137% vs 2023). filed late Source: NBB ↗
- Pharma Handshake BV became a director. NBB
In short
From € 13.2 million profit in 2021 to € 16.1 million loss in 2024.
Paid € 1,684 in corporate taxes since 2021.
Best year ever: 2023, with € 43.5 million profit.
Pays suppliers within 75 days on average.
A new publication or filing at A.forall Group? We notify you, reason included.
Follow A.forall GroupNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
It owns 100% of Medigroup and 100% of A.forall development itself.
Directors
According to the 2024 annual accounts
Managing director · represented by Filip Van de Vliet
Also active at: ECOPHARMASUPPLY DISTRIBUTION, ECO.PHARMA.SUPPLY, FYTEKO +2 more
since 2019 · until 2028
Karsten Langer
Director
since 2017 · until 2028
Damien Gaudin
Director
since 2017 · until 2028
George Frederick Wilkinson
Director
since 2018 · until 2028
Director · represented by Steen Vangsgaard
since 2025 · until 2028
VS Pharma Consulting LLC
Director · represented by Jatin Shah
since 2019 · until 2028
Establishments
Establishment units
Physical locations of this company
Marie Curiesquare 50
1070 Anderlecht
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 5 companies are registered at this address.
Details
- Company number
- 0684.777.042
- VAT number
- BE 0684.777.042
- Registered office
- Marie Curiesquare 50, 1070 Anderlecht
- Names & denominations
- A.forall Group
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 17 November 2017
- Peppol
- Active · Active since 6 Jan 2026
- Activities · NACE
Activiteiten van holdings
Overige zakelijke dienstverlening, neg
Holdings